The funding round was fully subscribed by an unnamed single strategic investor, with vast experience in the management of healthcare delivery in Malaysia.
The funds will be channeled towards refining MedPlanner’s all-in-one clinical app, as well as the marketing and commercialisation, as the company set out to launch in five countries next year. “This investment in MedPlanner will help us reach our goal of bringing our solution closer to the healthcare community while providing investors the opportunity to make substantial returns,” said Co-founder and CEO Dr. Ezam Mat-Ali.
MedPlanner was founded in 2017 by Mat-Ali, a consultant paediatrician at the London North West University Healthcare. The startup has developed a clinical communication platform for collaboration between clinicians around the world to facilitate better communication and coordination in patient care delivery. It seeks to mitigate poor communication amongst healthcare professionals and allows for the effective and safe transfer of information between healthcare practitioners specialist advice, referral and handover.
“With MedPlanner’s mobile app, clinicians can easily share results, obtain feedback on patients’ progress, and discuss multiple cases concurrently with their team. With over one million patient-related messages each day being processed over non-compliant chat apps in Malaysia’s public hospitals, we are in a unique position now to launch our solution into Malaysia’s healthcare industry,” said added Mat-Ali.
Kyri Andreou, Co-founder and Director of Ata Plus, said: “MedPlanner’s campaign has demonstrated to us once again the potential of ECF in Malaysia and the different groups of investors businesses attract with an ECF campaign — whether it be a large crowd of retail investors or a single individual investor. Since our launch, our platform has set the record for the largest number of investors in a single campaign (318 investors), the smallest minimum ticket size (RM 10), and now, the largest investment from a single investor (RM1 million).